T. Rowe Price Associates’s Endo International plc ENDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-128,452
| Closed | -$60K | – | 3087 |
|
|
2022
Q2 | $60K | Sell |
128,452
-425
| -0.3% | -$540 | ﹤0.01% | 2839 |
|
|
2022
Q1 | $298K | Buy |
128,877
+5,121
| +4% | +$15K | ﹤0.01% | 2554 |
|
|
2021
Q4 | $465K | Sell |
123,756
-86,675
| -41% | -$420K | ﹤0.01% | 2419 |
|
|
2021
Q3 | $682K | Buy |
210,431
+51,800
| +33% | +$183K | ﹤0.01% | 2230 |
|
|
2021
Q2 | $742K | Sell |
158,631
-6,690
| -4% | -$38.4K | ﹤0.01% | 2199 |
|
|
2021
Q1 | $1.23M | Sell |
165,321
-66,588
| -29% | -$540K | ﹤0.01% | 1960 |
|
|
2020
Q4 | $1.67M | Buy |
231,909
+30,307
| +15% | +$158K | ﹤0.01% | 1705 |
|
|
2020
Q3 | $665K | Buy |
201,602
+61,343
| +44% | +$197K | ﹤0.01% | 1977 |
|
|
2020
Q2 | $481K | Buy |
140,259
+18,335
| +15% | +$70.2K | ﹤0.01% | 2063 |
|
|
2020
Q1 | $451K | Sell |
121,924
-62,493
| -34% | -$317K | ﹤0.01% | 2034 |
|
|
2019
Q4 | $865K | Buy |
184,417
+11,795
| +7% | +$52.6K | ﹤0.01% | 1951 |
|
|
2019
Q3 | $554K | Buy |
172,622
+1,400
| +0.8% | +$4.51K | ﹤0.01% | 2055 |
|
|
2019
Q2 | $705K | Buy |
171,222
+497
| +0.3% | +$3.14K | ﹤0.01% | 1984 |
|
|
2019
Q1 | $1.37M | Buy |
170,725
+19,671
| +13% | +$185K | ﹤0.01% | 1720 |
|
|
2018
Q4 | $1.1M | Buy |
151,054
+67,832
| +82% | +$931K | ﹤0.01% | 1762 |
|
|
2018
Q3 | $1.4M | Buy |
83,222
+717
| +0.9% | +$10.2K | ﹤0.01% | 1727 |
|
|
2018
Q2 | $778K | Buy |
82,505
+393
| +0.5% | +$2.64K | ﹤0.01% | 1951 |
|
|
2018
Q1 | $488K | Buy |
82,112
+19,592
| +31% | +$137K | ﹤0.01% | 2100 |
|
|
2017
Q4 | $485K | Sell |
62,520
-19,630
| -24% | -$147K | ﹤0.01% | 2103 |
|
|
2017
Q3 | $704K | Buy |
82,150
+40
| +0% | +$385 | ﹤0.01% | 1944 |
|
|
2017
Q2 | $917K | Sell |
82,110
-612,195
| -88% | -$7.19M | ﹤0.01% | 1818 |
|
|
2017
Q1 | $7.75M | Sell |
694,305
-383,262
| -36% | -$4.76M | ﹤0.01% | 1376 |
|
|
2016
Q4 | $17.7M | Sell |
1,077,567
-360,298
| -25% | -$6.34M | ﹤0.01% | 1177 |
|
|
2016
Q3 | $29M | Buy |
1,437,865
+57,620
| +4% | +$1.15M | 0.01% | 999 |
|
|
2016
Q2 | $21.5M | Sell |
1,380,245
-1,470,548
| -52% | -$30.5M | ﹤0.01% | 1077 |
|
|
2016
Q1 | $80.3M | Buy |
2,850,793
+1,446,976
| +103% | +$68.3M | 0.02% | 612 |
|
|
2015
Q4 | $85.9M | Sell |
1,403,817
-27,200
| -2% | -$1.65M | 0.02% | 596 |
|
|
2015
Q3 | $99.1M | Buy |
1,431,017
+108,195
| +8% | +$8.66M | 0.02% | 576 |
|
|
2015
Q2 | $105M | Buy |
1,322,822
+194,200
| +17% | +$16.8M | 0.02% | 587 |
|
|
2015
Q1 | $101M | Buy |
1,128,622
+914,907
| +428% | +$76.5M | 0.02% | 606 |
|
|
2014
Q4 | $15.4M | Buy |
213,715
+9,104
| +4% | +$624K | ﹤0.01% | 1199 |
|
|
2014
Q3 | $14M | Buy |
204,611
+62,713
| +44% | +$4.13M | ﹤0.01% | 1217 |
|
|
2014
Q2 | $9.94M | Buy |
141,898
+97,906
| +223% | +$6.55M | ﹤0.01% | 1319 |
|
|
2014
Q1 | $3.02M | Buy |
43,992
+2,773
| +7% | +$197K | ﹤0.01% | 1499 |
|
|
2013
Q4 | $2.78M | Sell |
41,219
-5,200
| -11% | -$297K | ﹤0.01% | 1491 |
|
|
2013
Q3 | $2.11M | Sell |
46,419
-557,400
| -92% | -$22.4M | ﹤0.01% | 1541 |
|
|
2013
Q2 | $22.2M | Buy |
+603,819
| New | +$21.7M | 0.01% | 1040 |
|
Other funds holding ENDP
TCM
EDRH
CAM
HAIM
T. Rowe Price Associates's ENDP Position: Q3 2022 in Review
T. Rowe Price Associates sold out of Endo International plc (ENDP) in Q3 2022, closing a stake of 128,452 shares — an estimated $60K sold.
T. Rowe Price Associates first reported a position in ENDP in Q2 2013 and held it in 37 quarters. The position peaked at $105M in Q2 2015. 12 funds tracked by Wall St. Rank hold ENDP as of Q3 2022.
- T. Rowe Price Associates reported no remaining Endo International plc position as of Q3 2022 after selling out during the quarter.
- T. Rowe Price Associates sold 128,452 Endo International plc shares in Q3 2022, an estimated $60K.
- T. Rowe Price Associates first reported a position in Endo International plc in Q2 2013 and held it in 37 quarters.
- T. Rowe Price Associates's Endo International plc position peaked at $105M in Q2 2015.
- 12 funds tracked by Wall St. Rank held Endo International plc as of Q3 2022.
Based on T. Rowe Price Associates's 13F filing for Q3 2022, filed 14 Nov 2022.